Our study provides compelling evidence that HMGB2 plays a critical role in regulating the proliferative, migratory, and invasive capacities of cancer cells in female-specific cancers, including breast, cervical, ovarian, and endometrial cancers. Here, HMGB2 is linked to endometrial cancer.